Annals of Oncology

Pancreatico-Biliary Malignancy: Prevalence and Risk Factors
pp. 1-3(3)
Authors: Lowenfels A.B.; Maisonneuve P.

Progress in Cancer Genetics: Lessons from Pancreatic Cancer
pp. 4-8(5)
Authors: Goggins M.; Kern S.E.; Offerhaus J.A.; Hruban R.H.

Introduction
pp. 7-7(1)
Author: Tytgat G.N.J.

Pathology of Incipient Pancreatic Cancer
pp. 9-11(3)
Authors: Hruban R.H.; Wilentz R.E.; Goggins M.; Offerhaus G.J.A.; Yeo C.J.; Kern S.E.

Computed Tomography in the Diagnosis and Staging of Cholangiocarcinoma and Pancreatic Carcinoma
pp. 12-17(6)
Author: Freeny P.C.

MRI and MRCP in Pancreaticobiliary Malignancy
pp. 18-19(2)
Author: Ferrucci J.T.

Imaging and Staging of Biliopancreatic Malignancy: Role of Ultrasound
pp. 20-24(5)
Authors: Smits N.J.; Reeders J.W.A.J.

Imaging and Staging of Bilio-Pancreatic Tumours: Role of Endoscopic and Intraductal Ultrasonography and Guided Cytology
pp. 25-27(3)
Author: Palazzo L.

18FDG-Positron Emission Tomography in Pancreatic Cancer
pp. 28-32(5)
Authors: Zimny M.; Buell U.

Laparoscopic Staging of Biliopancreatic Malignancy
pp. 33-36(4)
Authors: Gouma D.J.; van Dijkum E.J.M.N.; de Wit L.T.; Obertop H.

Imaging of Pancreatic Adenocarcinoma with Radiolabeled Monoclonal Antibodies
pp. 37-40(4)
Author: Mariani G.

In Vitro Pancreatic Carcinogenesis
pp. 41-45(5)
Authors: Schmied B.M.; Ulrich A.; Matsuzaki H.; Li C.-H.; Pour P.M.

Invasion and Metastasis in Pancreatic Cancer
pp. 46-50(5)
Authors: Ellenrieder V.; Adler G.; Gress T.M.

Mucin Gene and Antigen Expression in Biliopancreatic Carcinogenesis
pp. 51-55(5)
Authors: Kim Y.S.; Gum Jr. J.R.; Crawley S.C.; Deng G.; Ho J.J.L.

DPC4/SMAD4 Gene Alterations in Human Cancer, and Their Functional Implications
pp. 56-59(4)
Author: Schutte M.

Angiogenesis and Anti-Angiogenesis: Perspectives for the Treatment of Solid Tumors
pp. 60-63(4)
Authors: van Hinsbergh V.W.M.; Collen A.; Koolwijk P.

Novel Technology for Detection of Genomic and Transcriptional Alterations in Pancreatic Cancer
pp. 64-68(5)
Authors: Wallrapp C.; Müller-Pillasch F.; Micha A.; Wenger C.; Geng M.; Solinas-Toldo S.; Lichter P.; Frohme M.; Hoheisel J.D.; Adler G.; Gress T.M.

Familial Pancreatic Cancer
pp. 69-73(5)
Authors: Hruban R.H.; Petersen G.M.; Goggins M.; Tersmette A.C.; Offerhaus G.J.A.; Falatko F.; Yeo C.J.; Kern S.E.

The Impact of Smoking on Future Pancreatic Cancer: A Computer Simulation
pp. 74-78(5)
Authors: Mulder I.; van Genugten M.L.L.; Hoogenveen R.T.; de Hollander A.E.M.; Bueno-de-Mesquita H.B.

Diabetes and the Risk of Pancreatic Cancer
pp. 79-81(3)
Author: Gullo L.

Vagaries of Clinical Presentation of Pancreatic and Biliary Tract Cancer
pp. 82-84(3)
Authors: Modolell I.; Guarner L.; Malagelada J.R.

Differential Diagnosis of Focal Pancreatitis and Pancreatic Cancer
pp. 85-88(4)
Authors: van Gulik T.M.; Moojen T.M.; van Geenen R.; Rauws E.A.J.; Obertop H.; Gouma D.J.

Primary Sclerosing Cholangitis and Cholangiocarcinoma as a Diagnostic and Therapeutic Dilemma
pp. 89-93(5)
Authors: van Leeuwen D.J.; Reeders J.W.A.J.

Choledochal Cystic Malignancies
pp. 94-98(5)
Authors: Bismuth H.; Krissat J.

Mucin Hypersecreting Neoplasms
pp. 99-103(5)
Author: Carr-Locke D.L.

Cystic Pancreatic Neoplasms
pp. 104-106(3)
Authors: Rattner D.W.; Fernandez-del Castillo C.; Warshaw A.L.

Role of Tumor Markers and Mutations in Cells and Pancreatic Juice in the Diagnosis of Pancreatic Cancer
pp. 107-110(4)
Authors: Tascilar M.; Caspers E.; Sturm P.D.J.; Goggins M.; Hruban R.H.; Offerhaus G.J.A.

Detection of Micrometastasis in Bone Marrow of Pancreatic Cancer Patients
pp. 111-113(3)
Authors: Thorban S.; Roder J.D.; Siewert J.R.

Diagnosis of Pancreatico-Biliary Malignancy: Detection of Gene Mutations in Plasma and Stool
pp. 114-117(4)
Authors: Mulcahy H.; Farthing M.J.G.

Usefulness of Novel Tumour Markers
pp. 118-121(4)
Author: Rhodes J.M.

Mechanisms of Biliary Carcinogenesis: A Pathogenetic Multi-Stage Cascade towards Cholangiocarcinoma
pp. 122-126(5)
Authors: Holzinger F.; Z'graggen K.; Büchler M.W.

Risk of Pancreatic and Periampullary Cancer Following Cholecystectomy
pp. 127-128(2)
Author: Gullo L.

Gallbladder Carcinoma
pp. 129-130(2)
Author: Levin B.

Other Risk Factors for Pancreatic Cancer: Hormonal Aspects
pp. 131-135(5)
Authors: Andrén-Sandberg Å.; Hoem D.; Bäckman P.L.

Histological and Genetic Changes in Malignant Transformation of Gallbladder Adenoma
pp. 136-139(4)
Authors: Watanabe H.; Date K.; Itoi T.; Matsubayashi H.; Yokoyama N.; Yamano M.; Ajioka Y.; Nishikura K.

Pancreatic Cancer: Clinical Presentation, Pitfalls and Early Clues
pp. 140-142(3)
Author: DiMagno E.P.

Biliopancreatic Malignancy Current Diagnostic Possibilities: An Overview
pp. 143-144(2)
Author: Ferrucci J.T.

Role of Tumour Markers, Cytogenetics
pp. 145-149(5)
Author: Lamerz R.

Essentials in Biliopancreatic Staging: A Decision Analysis
pp. 150-152(3)
Authors: Obertop H.; Gouma D.J.

Biliopancreatic Malignancy: Screening the at Risk Patient with Molecular Markers
pp. 153-156(4)
Author: Caldas C.

Current Chemotherapeutic Possibilities in Pancreaticobiliary Cancer
pp. 157-161(5)
Authors: van Riel J.M.G.H.; van Groeningen C.J.; Pinedo H.M.; Giaccone G.

Multidrug Resistance: A Solvable Problem?
pp. 162-164(3)
Author: Borst P.

Palliation of Pain and Jaundice: An Overview
pp. 165-169(5)
Author: Russell R.C.G.

Pancreatic Endocrine Tumors: Recent Advances
pp. 170-176(7)
Author: Jensen R.T.

Somatostatin Receptor Imaging and Therapy of Pancreatic Endocrine Tumors
pp. 177-181(5)
Authors: van Eijck C.H.J.; de Jong M.; Breeman W.A.P.; Slooter G.D.; Marquet R.L.; Krenning E.P.

Intraoperative Methods to Stage and Localize Pancreatic and Duodenal Tumors
pp. 182-184(3)
Author: Norton J.A.

Pancreatic Endocrine Tumours, Immunotherapy and Gene Therapy: Chemotherapy and Interferon Therapy of Endocrine Tumours
pp. 185-187(3)
Author: Veenhof C.H.N.

Gene Therapy for Pancreatic and Biliary Malignancies
pp. 188-192(5)
Authors: Aspinall R.J.; Lemoine N.R.

An Overview of Preventive Strategies for Pancreatic Cancer
pp. 193-196(4)
Author: Levin B.

Retinoids in Pancreatic Cancer
pp. 197-200(4)
Authors: Riecken E.O.; Rosewicz S.

Preventative Strategies for Periampullary Tumours in FAP
pp. 201-203(3)
Authors: Wallace M.H.; Phillips R.K.S.

Remote Partial Gastrectomy as a Risk Factor for Pancreatic Cancer: Potential for Preventive Strategies
pp. 204-207(4)
Authors: van Rees B.P.; Tascilar M.; Hruban R.H.; Giardiello F.M.; Tersmette A.C.; Offerhaus G.J.A.

Prevention of Bile Duct Cancer in Primary Sclerosing Cholangitis
pp. 208-211(4)
Author: Harrison P.M.

Local Resection of Benign Periampullary Tumors
pp. 212-214(3)
Authors: Treitschke F.; Beger H.G.

Role of Radiotherapy, in Particular Intraluminal Brachytherapy, in the Treatment of Proximal Bile Duct Carcinoma
pp. 215-220(6)
Authors: González D.G.; Gouma D.J.; Rauws E.A.J.; van Gulik T.M.; Bosma A.; Koedooder C.

Conformal irradiation for hepatobiliary malignancies
pp. 221-225(5)
Authors: Gunderson L.L.; Haddock M.G.; Foo M.L.; Todoroki T.; Nagorney D.

Studies of Intraoperative Radiotherapy in Carcinoma of the Pancreas
pp. 226-230(5)
Authors: Sindelar W.F.; Kinsella T.J.

Chemoradiation for Pancreatic and Biliary Cancer: Current Status of RTOG Studies
pp. 231-233(3)
Author: Rich T.A.

Experimental Drugs and Drug Combinations in Pancreatic Cancer
pp. 234-238(5)
Authors: Kroep J.R.; Pinedo H.M.; van Groeningen C.J.; Peters G.J.

Surgical Possibilities for Bile Duct Cancer: Standard Surgical Treatment
pp. 239-242(4)
Author: Benjamin I.S.

Local Resection of Biliopancreatic Cancer
pp. 243-246(4)
Authors: Gulik T.M.v.; Gerhards M.; de Vries J.; van Geenen R.; de Wit L.T.; Obertop H.; Gouma D.J.

Standard Surgical Treatment in Pancreatic Cancer
pp. 247-251(5)
Authors: Wagner M.; Dikopoulos N.; Kulli C.; Friess H.; Büchler M.W.

Surgical Possibilities for Pancreatic Cancer: Extended Resection
pp. 252-256(5)
Authors: Kremer B.; Vogel I.; Lüttges J.; Klöppel G.; Henne-Bruns D.

Complications after Resection of Biliopancreatic Cancer
pp. 257-260(4)
Authors: Gouma D.J.; van Gulik T.M.; de Wit L.T.; Obertop H.

Role of Endoscopic Stenting in the Duodenum
pp. 261-264(4)
Author: Carr-Locke D.L.

Pain Management of Pancreatic Cancer
pp. 265-268(4)
Authors: Andrén-Sandberg Å.; Viste A.; Horn A.; Hoem D.; Gislason H.

Surgical Palliative Treatment in Bilio-Pancreatic Malignancy
pp. 269-272(4)
Authors: Gouma D.J.; van Geenen R.; van Gulik T.; de Wit L.T.; Obertop H.

Nutritional Support during Treatment of Biliopancreatic Malignancy
pp. 273-277(5)
Author: von Meyenfeldt M.F.

Endoscopic Palliative Treatment of Advanced Pancreatic Cancer: Thoracoscopic Splanchnicectomy and Laparoscopic Gastrojejunostomy
pp. 278-280(3)
Authors: Giraudo G.; Kazemier G.; Van Eijck C.H.J.; Bonjer H.J.

Quality of Life, Nutritional Status and Gastrointestinal Hormone Profile following the Whipple Procedure
pp. 281-284(4)
Author: McLeod R.S.

The Future of Surgery for Pancreatic Cancer
pp. 285-290(6)
Authors: Slavin J.; Ghaneh P.; Jones L.; Sutton R.; Hartley M.; Neoptolemos J.P.

Future Role of Radiotherapy as a Component of Treatment in Biliopancreatic Cancers
pp. 291-295(5)
Authors: Gunderson L.L.; Haddock M.G.; Burch P.; Nagorney D.; Foo M.L.; Todoroki T.

Pancreaticobiliary Cancer: The Future Aspects of Medical Oncology
pp. 296-299(4)
Authors: van Riel J.M.G.H.; Giaccone G.; Pinedo H.M.

Biliopancreatic Malignancy: Future Prospects for Progress
pp. 300-304(5)
Authors: Ho J.J.L.; Kim Y.S.

Intravenous and Intra-Arterial Chemotherapeutic Possibilities in Biliopancreatic Cancer
pp. 305-307(3)
Author: van Groeningen C.J.

Risk Factors for Biliary Tract Carcinogenesis
pp. 308-311(4)
Author: Chapman R.W.

Subject Index
pp. 313-315(3)

Authors Index
pp. 317-318(2)